Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 154, Issue 4, 2006, Pages 563-568

  Yesilada, Elif ^a   Sahin, Hamdi ^a   Ozcan, Hamdi ^a   Yildrim, Ibrahim Halil ^a   Yologlu, Saim ^a   Taskapan, Cagatay ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINESIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; FREQUENCY ANALYSIS; GENETIC STABILITY; GLUCOSE BLOOD LEVEL; HIRSUTISM; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; LYMPHOCYTE CULTURE; MICRONUCLEUS; OVARY POLYCYSTIC DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RANK SUM TEST; SCORING SYSTEM; SOMATIC CELL GENETICS; TESTOSTERONE BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CELLS, CULTURED; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HIRSUTISM; HUMANS; INSULIN; INSULIN RESISTANCE; LUTEINIZING HORMONE; LYMPHOCYTES; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; POLYCYSTIC OVARY SYNDROME; PROLACTIN; TESTOSTERONE;

EID: 33646047399     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02117     Document Type: Article

References (51)

1. Franks S. Polycystic ovary syndrome. New England Journal of Medicine 1995 333 853-861.
2. Orio F Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanova L, Nardo LG, Labella D, Savastano S, Russo T, Zullo F, Colao A & Lombardi G. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2005 90 2-5.
3. Knochenhauer ES, Key TJ, Kashar-Miller M, Waggoner W, Boots LR & Aziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States; a prospective study. Journal of Clinical Endocrinology and Metabolism 1998 83 3078-3082.
4. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 2434-2438.
5. Escobar-Morreale HF, Luque-Ramirez M & San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews 2005 26 251-282.
6. Amato P & Simpson JL. The genetics of polycystic ovary syndrome. Best Practice and Research. Clinical Obstetrics and Gynaecology 2004 18 707-718.
7. Rojanasakul A, Gustavson KH, Lithell H & Nillius SJ. Tetraploidy in two sisters with the polycystic ovary syndrome. Clinical Genetics 1985 27 167-174.
8. Nur J, Grewal MS, Guron CJ & Buckshee K. C-band polymorphism of chromosome no. 1 in patients with polycystic ovary disease. Asia Oceania Journal of Obstetrics and Gynaecology 1987 13 75-78.
9. Meyer MF, Gerresheim F, Pfeiffer A, Epplen JT & Schatz H. Association of polycystic ovary syndrome with an interstitial deletion of the long arm of chromosome 11. Experimental and Clinical Endocrinology and Diabetes 2000 108 519-523.
10. Stenchever MF, Gerresheim F, Pfeffer A, Epplen JT & Schatz H. Cytogenetic evaluation of 41 patients with Stein-Leventhal syndrome. Obstetrics and Gynecology 1968 32 797-801.
11. Xita N, Georgiou I & Tsatsoulis A. The genetic basis of polycystic ovary syndrome. European Journal of Endocrinology 2002 147 717-725.
12. Fenech M & Morley AA. Measurement of micronuclei in lymphocytes. Mutation Research 1985 147 29-36.
13. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutation Research 1993 285 35-44.
14. Fenech M, Holland N, Chang WP, Zeiger E & Bonnasi S. The Human Micronucleus Project - an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutation Research 1999 428 271-283.
15. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Kirchner S, Lorge E, Morita T, Norppa H, Surralles J, Vanhauwaert A & Wakata A. Report from the in vitro micronucleus assay working group. Mutation Research 2003 540 153-163.
16. Rotterdam Eshe/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Human Reproduction 2004 19 41-47.
17. Hatch R, Rosenfield R, Kim MH & Tredway D. Hirsutism implications, etiology and management. American Journal of Obstetrics and Gynecology 1981 10 815-830.
18. Matthews DR, Hoske JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model of assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985 28 412-419.
19. Rosenfield RL. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America 1999 28 265-293.
20. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 774-800.
21. Sahin I, Serter R, Karakurt F, Demirbas B, Culha C, Taskapan C, Kosar F & Aral Y. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study. Gynecological Endocrinology 2004 19 115-124.
22. Nersesyan AK, Vardazaryan NS, Gevorgyan AC & Arutyunyan RM. Micronucleus level in exfoliated buccal mucosa cells of cancer patients. Archive of Oncology 2002 10 35-36.
23. Diaz S, Fonseca G & Fernandez I. Analysis of lymphocyte and oral mucosa cell micronuclei in Cuban paint industry workers. Hereditas 1990 113 77-80.
24. Burgaz S, Karahalil B, Bayrak P, Taskin L, Yavuzaslan F, Bokesoy I, Anzion RBM, Bos RP & Platin N. Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling anti-neoplastics. Mutation Research 1999 439 97-104.
25. Falck GCM, Hirvonen A, Scarpato R, Saarikoski ST, Migliore L & Norppa H. Micronuclei in blood lymphocytes and genetic polymorphism for GSTM1, GSTT1 and NAT2 in pesticide-exposed greenhouse workers. Mutation Research 1999 441 225-237.
26. Murrey EB & Edvards JW. Micronuclei in peripheral lymphocytes and exfoliated urothelial cells of workers exposed to 4,4′-methylenebis-(2-chloroaniline) (MOCA). Mutation Research 1999 446 175-180.
27. Trkova M, Kapras J, Bobkova K, Stankova J & Mejsnarova B. Increased micronuclei frequencies in couples with reproductive failure. Reproductive Toxicology 2000 14 331-335.
28. Botto N, Rizza A, Colombo MG, Mazzone AM, Manfredi S, Masetti S, Clerco A, Biagini A & Andreassi MG. Evidence for DNA damage in patients with coronary artery disease. Mutation Research 2001 493 23-30.
29. Baciuchka-Palmaro M, Orsière T, Duffaud F, Sari-Minodier I, Pompili J, Bellon L, De Méo M, Digue L, Favre R & Botta A. Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutation Research 2002 520 189-198.
30. Joksic G, Petrovic S & Ilic Z. Age-related changes in radiation-induced micronuclei among healthy adults. Brazilian Journal of Medical and Biological Research 2004 37 1111-1117.
31. Huber R, Braselmann H & Bauchiner M. Intra-and inter-individual variation of background and radiation-induced micronucleus frequencies in human lymphocytes. International Journal of Radiation Biology 1992 61 655-661.
32. Parker R, Ming PM, Rajan R, Goodner DM & Reme G. Clinical and cytogenetic studies with polycystic ovary disease. American Journal of Obstetrics and Gynecology 1980 137 656-660.
33. Hando JC, Nath J & Tucker JD. Sex chromosomes, micronuclei and aging in women. Chromosoma 1994 103 186-192.
34. Catalan J, Autio K, Wessman M, Lindholm C, Knuutila S, Sorsa M & Norppa H. Age-associated micronuclei containing centromeres and the X chromosome in lymphocytes in women. Cytogenetics and Cell Genetics 1995 68 11-16.
35. van der Spuy ZM & Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Practice and Research. Clinical Obstetrics and Gynaecology 2004 18 755-771.
36. Kousta E, White DM, Cela E, McCarthy MI & Franks S. The prevalence of polycystic ovaries in women with infertility. Human Reproduction 1999 14 2720-2723.
37. Balen AH, Conway GS, Kaltsas G, Techatraisak K, Manning PJ, West C & Jacobs HS. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction 1995 10 2107-2111.
38. Ames BN, Gold LS & Willett WC. The causes and prevention of cancer. PNAS 1995 92 5258-5265.
39. Simic MG. DNA markers of oxidative processes in vivo: relevance to carcinogenesis and anticarcinogenesis. Cancer Research 1994 54 1918-1923.
40. Sabuncu T, Vural H, Harma M & Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clinical Biochemistry 2001 34 407-413.
41. Fenkci V, Fenkci S, Yilmazer M & Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertility and Sterility 2003 80 123-127.
42. Karmakar R, Banik S, Bandyopadhyay S & Chatterjee M. Cadmium-induced alterations of hepatic lipid peroxidation, glutathione S-transferase activity and reduced glutathione level and their possible correlation with chromosomal aberration in mice: a time course study. Mutation Research 1998 397 183-190.
43. Mayer C, Schmezer P, Freese R, Mutanen M, Hietanen E, Obe G, Basu S & Bartsch H. Lipid peroxidation status, somatic mutations and micronuclei in peripheral lymphocytes: a case observation on a possible interrelationship. Cancer Letters 2000 152 169-173.
44. Chandra Mohan KVP & Nagini S. Dose-response effects of tomato lycopene on lipid peroxidation and enzymic antioxidants in the hamster buccal pouch carcinogenesis model. Nutrition Research 2003 23 1403-1416.
45. Subapriya R, Kumaraguruparan R, Abraham SK & Nagini S. Protective effects of ethanolic neem leaf extract on N-methyl-N-nitro-N-nitrosoguanidine-induced genotoxicity and oxidative stress in mice. Drug and Chemical Toxicology 2004 27 15-26.
46. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K & Kuller L. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 821-826.
47. Orio F Jr, Palomba S, Spinelli L, Palomba S, Tauchmanova L, Zullo F, Lombardi G & Colao A. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. Journal of Clinical Endocrinology and Metabolism 2004 89 3696-3701.
48. Hardiman P, Pillay OS & Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003 361 1810-1812.
49. Gadducci A, Gargini A, Palla E, Fanucchi A & Genazzani AR. Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecological Endocrinology 2005 20 200-208.
50. Duffaud E, Orsiere T, Villant P, Pellissier AL, Volot E, Favre R & Botta A. Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patients. Mutagenesis 1997 12 227-231.
51. Jagetia GC, Jayakrishnan A, Fernandes D & Vidyasagar MS. Evaluation of micronuclei frequency in the cultured peripheral blood lymphocytes of cancer patients before and after radiation treatment. Mutation Research 2001 491 9-16.